Publication
Development and Validation of a GC–MS-EI Method to Determine α-PHP in Blood: Application to Samples Collected during Medico-Legal Autopsies
| dc.contributor.author | Machado, Francisca | |
| dc.contributor.author | Franco, João Miguel | |
| dc.contributor.author | Vieira, Duarte Nuno | |
| dc.contributor.author | Margalho, Cláudia | |
| dc.date.accessioned | 2023-02-08T15:37:17Z | |
| dc.date.available | 2023-02-08T15:37:17Z | |
| dc.date.issued | 2022-12-14 | |
| dc.description.abstract | New psychoactive substances (NPSs) still represent an issue of great concern worldwide despite efforts made by national and international control systems to limit the spread of these substances. Alpha-pyrrolidinohexanophenone (α-PHP) is a fairly recent synthetic cathinone (the second largest group of monitored substances in Europe) with only a few published studies on the substance. Though there is a low incidence of NPS consumption in Portugal, a recent increase in apprehensions and detections in biological matrices of the substance was verified. An analytical methodology was developed and validated for determining and quantitating α-PHP in blood. Solid-phase extraction was employed for sample preparation (500 μL), which was further analyzed by gas chromatography-mass spectrometry-electron ionization in single-ion monitoring mode with cocaine-d3 as the internal standard. Method validation followed the guidelines of the American National Standards Institute/AAFS Standards Board (ANSI/ASB Standard 036). The procedure was linear between 10 and 1,000 ng/mL, with determination coefficients (r2) higher than 0.999. Carryover was not observed. A limit of detection of 5 ng/mL and a limit of quantitation of 10 ng/mL were achieved. Intraday and intermediate precision and bias assessment showed satisfactory results (coefficient of variation <17.7%; bias <11.6%), and extraction efficiency ranged from 98.5% to 103.3%. The stability of the substance was considered acceptable for at least 6 h at room temperature, 48 h in the autosampler and 21 days after five freeze/thaw cycles. The developed methodology was applied to 15 real samples from the Laboratory of Chemistry and Forensic Toxicology, Centre Branch of the National Institute of Legal Medicine and Forensic Sciences, Portugal, with drug concentrations ranging from 15 to 227 ng/mL. Available information for each case is also detailed in the present article. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | Francisca Machado, João Franco, Duarte Nuno Vieira, Cláudia Margalho, Development and Validation of a GC–MS-EI Method to Determine α-PHP in Blood: Application to Samples Collected during Medico-Legal Autopsies, Journal of Analytical Toxicology, 2022;, bkac104, https://doi.org/10.1093/jat/bkac104 | pt_PT |
| dc.identifier.doi | 10.1093/jat/bkac104 | pt_PT |
| dc.identifier.uri | http://hdl.handle.net/10400.26/43729 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.publisher | Oxford | pt_PT |
| dc.subject | α-PHP | pt_PT |
| dc.subject | GC-MS-EI | pt_PT |
| dc.subject | New Psychoactive Substances | pt_PT |
| dc.subject | SPE | pt_PT |
| dc.subject | Synthetic Cathinones | pt_PT |
| dc.title | Development and Validation of a GC–MS-EI Method to Determine α-PHP in Blood: Application to Samples Collected during Medico-Legal Autopsies | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | 9 | pt_PT |
| oaire.citation.startPage | 1 | pt_PT |
| oaire.citation.title | Journal of Analytical Toxicology | pt_PT |
| oaire.citation.volume | 00 | pt_PT |
| person.familyName | Franco | |
| person.familyName | Margalho | |
| person.givenName | João | |
| person.givenName | Cláudia | |
| person.identifier.ciencia-id | A211-521D-90CA | |
| person.identifier.orcid | 0000-0002-3268-3841 | |
| person.identifier.orcid | 0000-0003-1661-0367 | |
| person.identifier.rid | KII-2916-2024 | |
| person.identifier.scopus-author-id | 8655072100 | |
| rcaap.rights | closedAccess | pt_PT |
| rcaap.type | article | pt_PT |
| relation.isAuthorOfPublication | 045c4125-1313-445f-b05f-b7f204886052 | |
| relation.isAuthorOfPublication | 267f4998-7eea-4d9f-9216-8adcd52fbe1f | |
| relation.isAuthorOfPublication.latestForDiscovery | 045c4125-1313-445f-b05f-b7f204886052 |